Illegale Opiatsucht, Behandlung und ökonomische Kostenforschung - ein beispielhafter Überblick und eine Diskussion aus sozialwissenschaftlicher Perspektive

Fischer, Benedikt

doi:10.1055/s-2003-38097

Cited by 6 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The role of social determinants in predicting harm outcomes among drug-using populations has also been demonstrated more broadly (69,121,122). A different perspective on the interactions between individual and social harms is that most social costs related to illicit opioid use in Canada-estimated to be in the range of billions of dollars-are for crime and criminal justice expenditures (79).…”

Section: Discussionmentioning

confidence: 99%

“…For example, homelessness or incarceration status have been found to predict both infectious disease transmission and overdose occurrence in illicit opioid and other drug users (50,69,77,78). Second, from a social cost perspective, the economic costs of crime (that is, victimization) and criminal justice expenditures (that is, policing, courts, and corrections) comprise most (about 80%) of the social cost burden imposed on society by illicit opioid use (79,80). Consequently, programs and policies with an interest in reducing this societal burden ought to support interventions that effectively lower activities and harms related to illicit opioid use in these areas.…”

Section: Socioeconomic Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)

2006

Self Cite

View full text Add to dashboard Cite

Clinical Implications • Illicit opioid use to a large extent manifests via the illicit use of prescription opioids and typically includes polysubstance use. • Physical and (or) mental health comorbidities are highly prevalent in illicit opioid user populations. • Morbidity and (or) mortality risks are often associated with social marginalization. Limitations • Little is known about the patterns and consequences of illicit opioid use in general populations. • Owing to the marginalized and illegal status of illicit opioid users, information is available only from selective populations with limited potential for generalizability of data. • The OPICAN study specifically builds largely on self-report and may be subject to bias. Objectives: To summarize key characteristics and consequences of illicit opioid use from the literature and to present corresponding data from a multisite sample of illicit opioid users in 5 Canadian cities (OPICAN study). Method: We undertook an overview of recent literature from North America, Australia, and Europe. We obtained data from the multicity OPICAN cohort study, which consisted of an interviewer-administered questionnaire, a standardized mental health instrument (the Composite International Diagnostic Interview Short Form for depression), and saliva-antibody tests for infectious disease (that is, HIV and hepatitis C virus). The baseline sample (n = 679) was collected in 2002. Results: Illicit opioid use in Canada and elsewhere is becoming increasingly heterogeneous in terms of opioid drugs used, with heroin playing an increasingly minor role; further, it predominantly occurs in a context of polydrug use (for example, cocaine-crack or benzodiazepines). Large proportions of illicit opioid users have physical and (or) mental health comorbidities, including infectious disease and (or) depression, and therefore require integrated interventions. Finally, morbidity risks among illicit opioid users are often predicted by social marginalization factors, for example, housing status or involvement in crime. Conclusions: Given the epidemiologic profile and high disease burden associated with contemporary forms of illicit opioid use, more effective treatment approaches are urgently needed in Canada and elsewhere. Specifically, treatment must adjust to the extensive polysubstance use realities, yet it must also more effectively address the complex physical and (or) mental health comorbidities presented by this high-risk population.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Socioeconomic Characteristicsmentioning

confidence: 99%

Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)

2006

Self Cite

View full text Add to dashboard Cite

show abstract

“…In einem Übersichtsartikel stellt Fischer internationale alte und aktuelle Zahlen zu den Behandlungskosten, den Produktivitätsverlusten und den Kosten durch Kriminalität und für die Strafverfolgung dar [30]. 1992 lagen die Behandlungskosten in Deutschland bei etwa 600 Mio.…”

Section: Einordnung Der Behandlungskostenunclassified

Anforderungen an ein regionalisiertes medizinisches Versorgungssystem für Drogenabhängige

Schmidt

Cranach

Egger

2006

Wien Med Wochenschr

View full text Add to dashboard Cite

Modern services for persons with disorders resulting from psychoactive drug abuse must conform to the complexity of their needs. Low threshold access, standards for the prescription of opiates, out-patient, in-patient and day-hospital detoxification, rehabilitation and abstinence oriented strategies are fundamental prerequisites. The quality of services for drug dependent patients is defined by the percentage finding access to the service, the percentage of those continuing in the service, the easy and rapid transition between the different elements of the service, the degree of abstinence, decriminalization, physical comorbidity and mortality. Finally the cost of treated and untreated drug dependence should be considered.

show abstract

Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics

Fischer

Oviedo‐Joekes

Blanken³

et al. 2007

J Urban Health

Self Cite

112

View full text Add to dashboard Cite

Since the initial Swiss heroin-assisted treatment (HAT) study conducted in the mid-1990s, several other jurisdictions in Europe and North America have implemented HAT trials. All of these studies embrace the same goal-investigating the utility of medical heroin prescribing for problematic opioid users-yet are distinct in various key details. This paper briefly reviews (initiated or completed) studies and their main parameters, including primary research objectives, design, target populations, outcome measures, current status and-where available-key results. We conclude this overview with some final observations on a decade of intensive HAT research in the jurisdictions examined, including the suggestion that there is a mounting onus on the realm of politics to translate the-largely positive-data from completed HAT science into corresponding policy and programming in order to expand effective treatment options for the high-risk population of illicit opioid users.

show abstract

Illegale Opiatsucht, Behandlung und ökonomische Kostenforschung - ein beispielhafter Überblick und eine Diskussion aus sozialwissenschaftlicher Perspektive

Cited by 6 publications

References 10 publications

Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)

Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)

Anforderungen an ein regionalisiertes medizinisches Versorgungssystem für Drogenabhängige

Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics

Contact Info

Product

Resources

About